157 related articles for article (PubMed ID: 9636693)
1. Enhancement of T-cell-mediated arthritis in mice by treatment with a monoclonal antibody against interleukin-4.
Yoshino S; Yoshino J
Cell Immunol; 1998 May; 185(2):153-7. PubMed ID: 9636693
[TBL] [Abstract][Full Text] [Related]
2. Effect of a monoclonal antibody against interleukin-4 on suppression of antigen-induced arthritis in mice by oral administration of the inducing antigen.
Yoshino S; Yoshino J
Cell Immunol; 1998 Aug; 187(2):139-44. PubMed ID: 9732702
[TBL] [Abstract][Full Text] [Related]
3. Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice.
Yoshino S
Br J Pharmacol; 1998 Jan; 123(2):237-42. PubMed ID: 9489611
[TBL] [Abstract][Full Text] [Related]
4. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4.
Yoshino S; Murata Y; Ohsawa M
J Immunol; 1998 Dec; 161(12):6904-8. PubMed ID: 9862723
[TBL] [Abstract][Full Text] [Related]
5. Reduction of arthritis severity in protease-activated receptor-deficient mice.
Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
7. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
8. Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization.
Yoshino S
Cell Immunol; 1995 Jun; 163(1):55-8. PubMed ID: 7758130
[TBL] [Abstract][Full Text] [Related]
9. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
Yoshino S
J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis.
Boe A; Baiocchi M; Carbonatto M; Papoian R; Serlupi-Crescenzi O
Cytokine; 1999 Dec; 11(12):1057-64. PubMed ID: 10623431
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.
Lawlor KE; Campbell IK; O'Donnell K; Wu L; Wicks IP
Arthritis Rheum; 2001 Feb; 44(2):442-50. PubMed ID: 11229476
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis.
Patel M; Xu D; Kewin P; Choo-Kang B; McSharry C; Thomson NC; Liew FY
Eur J Immunol; 2005 Dec; 35(12):3581-90. PubMed ID: 16285015
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.
Nissler K; Pohlers D; Hückel M; Simon J; Bräuer R; Kinne RW
Ann Rheum Dis; 2004 Nov; 63(11):1470-7. PubMed ID: 15479897
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
18. IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta.
Park Y; Kim HS; Ahn JY; Yun D; Cho ML; Hong S; Kim HY; Chung DH
J Immunol; 2010 Aug; 185(3):1476-84. PubMed ID: 20581146
[TBL] [Abstract][Full Text] [Related]
19. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: studies on the characteristics of and mechanisms involved in the reaction.
Lens JW; van den Berg WB; van de Putte LB
Clin Exp Immunol; 1984 Feb; 55(2):287-94. PubMed ID: 6199138
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
